First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy

Good News Network ·
Good News United Kingdom

A one-time infusion of CRISPR gene editing therapy slashed dangerous cholesterol by 52%, with the patients still experiencing the benefit 12 months after initial treatment, and without side effects. The Cleveland Clinic in Ohio reported that their Phase 1 human trial showed a one-time infusion of a gene-editing therapy using CRISPR-Cas9 was effective and safe […] The post First Human Trial to…

Read original article on Good News Network →